Average 50M shares a day now. Partnerships are in work and a share subscription is currently in place with GEM for financing. They wont be paying $.5s... 22.1B OS with the support dwindling with the lower volume. $.03 to $.06 shares from GEM? A double from here ($.5s) will take LOTS of effort and huge share trades. Great concept / drug / treatment possibly but that huge OS will be an issue. R/S? maybe.